Sarepta Therapeutics
SRPT
SRPT
317 hedge funds and large institutions have $7.9B invested in Sarepta Therapeutics in 2018 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 74 increasing their positions, 124 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.14% more ownership
Funds ownership: 87.36% → 91.5% (+4.1%)
9% more call options, than puts
Call options by funds: $349M | Put options by funds: $322M
40% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 124
Holders
317
Holding in Top 10
13
Calls
$349M
Puts
$322M
Top Buyers
| 1 | +$145M | |
| 2 | +$141M | |
| 3 | +$127M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$126M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$104M |
Top Sellers
| 1 | -$182M | |
| 2 | -$101M | |
| 3 | -$67.2M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
-$56.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$54.9M |